Department of Oncology, Odense University Hospital, Odense, Denmark.
Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.
Radiother Oncol. 2024 Jul;196:110284. doi: 10.1016/j.radonc.2024.110284. Epub 2024 Apr 16.
Treatment planning using a five-millimetre geometrical margin from GTV to high-dose CTV (CTV1) has been used in DAHANCA treatment centres since 2013. We aimed to evaluate changes in CTV1 volumes, local control (LC), and recurrence pattern after the implementation of five-millimetre geometrical margins nationally.
1,948 patients with pharyngeal, and laryngeal squamous cell carcinomas completed definitive IMRT-based treatment in 2010-2012 and 2013-2015 in three centres. The patient-specific margin was calculated as median surface distance from primary tumour GTV (GTV-T) to CTV1. Radiologically verified local recurrences were analysed using a centre of mass (COM) of the delineated recurrence volume, measuring the shortest distance between COM to GTV-T and CTV1 boundaries.
Median GTV-CTV1 was 0.9 (0.0-0.97) and 0.47 cm (0.4-0.5) for 2010-2012 and 2013-2015, respectively. Median CTV1 changed in three centres from 76, 28, 42 cm to 61, 53, 62 cm for 2010-2012 and 2013-2015, respectively. Local failures occurred at 247 patients during first three years after radiotherapy. The 3-year LC rate for 2010-2012 and 2013-2015 was 0.84 and 0.87 (p = 0.06). Out of 146 radiology-verified analysable local recurrences, 102 (69.9%) were inside the CTV1. In 74.6% and 91% of cases, the LRs were covered by 95% isodose in 2010-2012 and 2013-2015, respectively.
DAHANCA radiotherapy guidelines based on a geometrically generated isotropic CTV1 margin led to less variation in treatment volumes and between centres than previous guidelines. The transition towards consensus GTV-CTV1 margins did not influence local tumour control. The majority of local recurrences were inside CTV1 and covered by the prescription dose.
自 2013 年以来,DAHANCA 治疗中心一直采用从 GTV 到高剂量 CTV1(CTV1)的五毫米几何边界进行治疗计划。我们旨在评估全国范围内实施五毫米几何边界后 CTV1 体积、局部控制(LC)和复发模式的变化。
2010-2012 年和 2013-2015 年,三个中心的 1948 名咽和喉鳞状细胞癌患者接受了基于 IMRT 的确定性治疗。患者特定的边界是从原发肿瘤 GTV(GTV-T)到 CTV1 的中值表面距离计算得出的。使用划定的复发体积的质心(COM)分析放射学证实的局部复发,测量 COM 到 GTV-T 和 CTV1 边界之间的最短距离。
2010-2012 年和 2013-2015 年,中位 GTV-CTV1 分别为 0.9(0.0-0.97)和 0.47cm(0.4-0.5)。2010-2012 年和 2013-2015 年,三个中心的 CTV1 中位数分别从 76、28、42cm 变为 61、53、62cm。放射治疗后前三年共发生 247 例局部失败。2010-2012 年和 2013-2015 年的 3 年 LC 率分别为 0.84 和 0.87(p=0.06)。146 例可分析的放射学证实局部复发中,102 例(69.9%)位于 CTV1 内。在 2010-2012 年和 2013-2015 年,分别有 74.6%和 91%的病例中,LR 被 95%等剂量线覆盖。
基于几何生成各向同性 CTV1 边界的 DAHANCA 放射治疗指南导致治疗体积和中心之间的变化小于以前的指南。向共识 GTV-CTV1 边界的转变并未影响局部肿瘤控制。大多数局部复发位于 CTV1 内,并被处方剂量覆盖。